COMPOSITIONS AND METHODS FOR REDUCING OXIDATION OF IGF⿐1/IGFBP

The present invention provides, among other things, compositions and methods for reducing oxidation of a complex comprising insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3), for treating diseases and complications of prematurity. In some embodiments, th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HAHN Michael, LOWE Kris, TAYLOR Katherine, SALAMAT-MILLER Nazila
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HAHN Michael
LOWE Kris
TAYLOR Katherine
SALAMAT-MILLER Nazila
description The present invention provides, among other things, compositions and methods for reducing oxidation of a complex comprising insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3), for treating diseases and complications of prematurity. In some embodiments, the methods comprise adding antioxidants. In some embodiments, the antioxidants are methionine or sodium thiosulfate. In some aspects, the compositions provided are stable, pure and potent compositions comprising IGF-1 and IGFBP-3. In some aspects, the formulation is lyophilized. La presente invención proporciona, entre otras cosas, composiciones y métodos para reducir la oxidación de un complejo que comprende el factor de crecimiento similar a la insulina-1 (IGF-1) y la proteína de unión al factor de crecimiento similar a la insulina-3 (IGFBP-3), para tratar enfermedades y complicaciones de la prematuridad. En algunas modalidades, los métodos comprenden la adición de antioxidantes. En algunas modalidades, los antioxidantes son metionina o tiosulfato de sodio. En algunos aspectos, las composiciones proporcionadas son composiciones estables, puras y potentes que comprenden IGF-1 e IGFBP-3. En algunos aspectos, la formulación se liofiliza.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2024008819A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2024008819A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2024008819A3</originalsourceid><addsrcrecordid>eNrjZHB29vcN8A_2DPH09wtWcPRzUfB1DfHwdwlWcPMPUghydQl19vRzV_CP8HRxBKlR8HdT8HR3O7zo0P5DEwz1gUynAB4G1rTEnOJUXijNzaDk5hri7KGbWpAfn1pckJicmpdaEu8bYWRgZGJgYGFhaOloTJQiAILdLng</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITIONS AND METHODS FOR REDUCING OXIDATION OF IGF⿐1/IGFBP</title><source>esp@cenet</source><creator>HAHN Michael ; LOWE Kris ; TAYLOR Katherine ; SALAMAT-MILLER Nazila</creator><creatorcontrib>HAHN Michael ; LOWE Kris ; TAYLOR Katherine ; SALAMAT-MILLER Nazila</creatorcontrib><description>The present invention provides, among other things, compositions and methods for reducing oxidation of a complex comprising insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3), for treating diseases and complications of prematurity. In some embodiments, the methods comprise adding antioxidants. In some embodiments, the antioxidants are methionine or sodium thiosulfate. In some aspects, the compositions provided are stable, pure and potent compositions comprising IGF-1 and IGFBP-3. In some aspects, the formulation is lyophilized. La presente invención proporciona, entre otras cosas, composiciones y métodos para reducir la oxidación de un complejo que comprende el factor de crecimiento similar a la insulina-1 (IGF-1) y la proteína de unión al factor de crecimiento similar a la insulina-3 (IGFBP-3), para tratar enfermedades y complicaciones de la prematuridad. En algunas modalidades, los métodos comprenden la adición de antioxidantes. En algunas modalidades, los antioxidantes son metionina o tiosulfato de sodio. En algunos aspectos, las composiciones proporcionadas son composiciones estables, puras y potentes que comprenden IGF-1 e IGFBP-3. En algunos aspectos, la formulación se liofiliza.</description><language>eng ; spa</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240917&amp;DB=EPODOC&amp;CC=MX&amp;NR=2024008819A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25553,76306</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240917&amp;DB=EPODOC&amp;CC=MX&amp;NR=2024008819A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HAHN Michael</creatorcontrib><creatorcontrib>LOWE Kris</creatorcontrib><creatorcontrib>TAYLOR Katherine</creatorcontrib><creatorcontrib>SALAMAT-MILLER Nazila</creatorcontrib><title>COMPOSITIONS AND METHODS FOR REDUCING OXIDATION OF IGF⿐1/IGFBP</title><description>The present invention provides, among other things, compositions and methods for reducing oxidation of a complex comprising insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3), for treating diseases and complications of prematurity. In some embodiments, the methods comprise adding antioxidants. In some embodiments, the antioxidants are methionine or sodium thiosulfate. In some aspects, the compositions provided are stable, pure and potent compositions comprising IGF-1 and IGFBP-3. In some aspects, the formulation is lyophilized. La presente invención proporciona, entre otras cosas, composiciones y métodos para reducir la oxidación de un complejo que comprende el factor de crecimiento similar a la insulina-1 (IGF-1) y la proteína de unión al factor de crecimiento similar a la insulina-3 (IGFBP-3), para tratar enfermedades y complicaciones de la prematuridad. En algunas modalidades, los métodos comprenden la adición de antioxidantes. En algunas modalidades, los antioxidantes son metionina o tiosulfato de sodio. En algunos aspectos, las composiciones proporcionadas son composiciones estables, puras y potentes que comprenden IGF-1 e IGFBP-3. En algunos aspectos, la formulación se liofiliza.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHB29vcN8A_2DPH09wtWcPRzUfB1DfHwdwlWcPMPUghydQl19vRzV_CP8HRxBKlR8HdT8HR3O7zo0P5DEwz1gUynAB4G1rTEnOJUXijNzaDk5hri7KGbWpAfn1pckJicmpdaEu8bYWRgZGJgYGFhaOloTJQiAILdLng</recordid><startdate>20240917</startdate><enddate>20240917</enddate><creator>HAHN Michael</creator><creator>LOWE Kris</creator><creator>TAYLOR Katherine</creator><creator>SALAMAT-MILLER Nazila</creator><scope>EVB</scope></search><sort><creationdate>20240917</creationdate><title>COMPOSITIONS AND METHODS FOR REDUCING OXIDATION OF IGF⿐1/IGFBP</title><author>HAHN Michael ; LOWE Kris ; TAYLOR Katherine ; SALAMAT-MILLER Nazila</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2024008819A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>HAHN Michael</creatorcontrib><creatorcontrib>LOWE Kris</creatorcontrib><creatorcontrib>TAYLOR Katherine</creatorcontrib><creatorcontrib>SALAMAT-MILLER Nazila</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HAHN Michael</au><au>LOWE Kris</au><au>TAYLOR Katherine</au><au>SALAMAT-MILLER Nazila</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITIONS AND METHODS FOR REDUCING OXIDATION OF IGF⿐1/IGFBP</title><date>2024-09-17</date><risdate>2024</risdate><abstract>The present invention provides, among other things, compositions and methods for reducing oxidation of a complex comprising insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3), for treating diseases and complications of prematurity. In some embodiments, the methods comprise adding antioxidants. In some embodiments, the antioxidants are methionine or sodium thiosulfate. In some aspects, the compositions provided are stable, pure and potent compositions comprising IGF-1 and IGFBP-3. In some aspects, the formulation is lyophilized. La presente invención proporciona, entre otras cosas, composiciones y métodos para reducir la oxidación de un complejo que comprende el factor de crecimiento similar a la insulina-1 (IGF-1) y la proteína de unión al factor de crecimiento similar a la insulina-3 (IGFBP-3), para tratar enfermedades y complicaciones de la prematuridad. En algunas modalidades, los métodos comprenden la adición de antioxidantes. En algunas modalidades, los antioxidantes son metionina o tiosulfato de sodio. En algunos aspectos, las composiciones proporcionadas son composiciones estables, puras y potentes que comprenden IGF-1 e IGFBP-3. En algunos aspectos, la formulación se liofiliza.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_MX2024008819A
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title COMPOSITIONS AND METHODS FOR REDUCING OXIDATION OF IGF⿐1/IGFBP
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T07%3A58%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HAHN%20Michael&rft.date=2024-09-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2024008819A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true